Research with one goal: end cancer
At MD Anderson, some of the best minds in the world work in partnership with our patients to enable groundbreaking research to better treat and prevent cancer. Here, researchers have the freedom and support to follow a hypothesis and test new theories that can yield breakthroughs that transform the field and the lives of patients. Embedded in the fourth-largest U.S. city — and the most ethnically diverse — our teams work with our neighbors in the Texas Medical Center, the world’s largest medical center, and around the globe to advance our science and to serve our patients. From the first spark of an idea to its translation in our world-leading clinics, we remain invested and determined in our collective focus to end cancer.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
A sense of community
Katy Rezvani, M.D., Ph.D.
Professor, Department of Stem Cell Transplantation
Director of Translational Research
There is a sense of community in terms of ‘let’s come together and develop treatments for our patients that could be life-changing.'
Faculty elected to NAM
Breast cell atlas
A new era to end cancer
What is spatial omics?
Inhibitor drug trials
Lung cancer treatment
Kidney cancer insights
MD Anderson at ESMO
At the 2023 European Society for Medical Oncology (ESMO) Congress, our experts showcased their pacesetting research and joined colleagues for discussion on the latest advances in oncology.
Research by the Numbers
patents awarded to MD Anderson
patients in clinical trials
invested in research
MD Anderson was awarded more NCI-funded projects than any other U.S. institution in FY22. In addition, MD Anderson's research and training are aided by more than $168 million in NIH grant funding, which helps power our mission to end cancer.View our NIH award summary
Explore the work of our investigators
MD Anderson faculty focus on a variety of research topics that contribute to our goal of ending cancer.